Rate of progression to ESRD |
Lognormal |
μ = −2.333;σ = 0.406 |
CKD stage 4 mortality |
Lognormal |
μ = −2.577;σ = 0.415 |
Mortality on dialysis with CVC in first three months |
Lognormal |
μ = −5.473;σ = 0.604 |
Mortality on dialysis with CVC after three months |
Lognormal |
μ = −6.215;σ = 0.759 |
Mortality on dialysis with AVF in first three months |
Lognormal |
μ = −6.320;σ = 0.901 |
Mortality on dialysis with AVF after three months |
Lognormal |
μ = −6.645;σ = 0.724 |
Patient refusal for an AVF |
Beta |
r = 28;n = 599 |
Central vein stenosis |
Beta |
r = 10;n = 599 |
Heart Failure due to AVF |
Lognormal |
μ = −9.210;σ: 0.601 |
Mortality due to heart failure |
Beta |
r = 5;n = 404 |
Surgical mortality |
Beta |
r = 1;n = 1000 |
Ischemic steal syndrome |
Lognormal |
μ = −2.987;σ = 0.768 |
AVF Failure: first three months |
Lognormal |
μ = −3.689;σ = 1.010 |
AVF Failure: after three months |
Lognormal |
μ = −4.135;σ = 0.970 |
AVF failure on dialysis |
Lognormal |
μ = −4.605;σ = 1.177 |
Utility of CKD stage 4 |
Triangular |
low = 0.40; most likely = 0.62; high = 0.84 |
Utility of dialysis |
Triangular |
low = 0.20; most Likely = 0.51; high = 0.82 |